⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1242860 | 0.97 | L3MBTL1 (0.38) | — | |
| Hydrochloric Acid SCHEMBL3873748 | 0.95 | L3MBTL1 (0.37) | — | |
| SCHEMBL790285 | 0.94 | — | — | |
| SCHEMBL5149419 | 0.88 | — | — | |
| Pyrrolidine SCHEMBL2830893 | 0.87 | CA2 (0.38) | — | |
| SCHEMBL28062708 | 0.80 | CA2 (0.41) | — | |
| SCHEMBL1764108 | 0.80 | CA2 (0.36) | — | |
| SCHEMBL250579 | 0.77 | CA2 (0.38) | — | |
| SCHEMBL128860 | 0.77 | KDM4E (0.45) | — | |
| SCHEMBL929174 | 0.77 | L3MBTL3 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108324945-A | For inhibiting Nano medication particle to penetrate the inhibitor of placental barrier | 首都医科大学附属北京妇产医院 | 2018-07-27 | — | — | CN | claimed |
| EP-1189061-B1 | Multifunctional erythrocyte reagent containing carbamates and uses | IMMUNOTECH SA (FR) | 2009-12-02 | — | — | EP | claimed |
| US-20020115118-A1 | Multi-functional reagent for erythrocytes | IMMUNOTECH (FR) | 2002-08-22 | — | — | US | claimed |
| EP-0202048-B1 | CARBAPENEM DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1991-10-30 | — | — | EP | claimed |
| US-4771046-A | ANTIBIOTICS | SANKYO COMPANY, LIMITED (JP) | 1988-09-13 | — | — | US | claimed |
| EP-0202048-A1 | Carbapenem derivatives, their preparation, and pharmaceutical compositions containing them | SANKYO COMPANY LIMITED (JP) | 1986-11-20 | — | — | EP | claimed |
| WO-2025226622-A1 | TIGILANOL TIGLATE ANALOGS, PHORBOL ANALOGS, PRODRUGS, SYNTHETIC METHODS, AND METHODS OF USE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-10-30 | — | — | WO | disclosed |
| CN-118804981-A | Method for processing biomass material | 普罗奥尼克股份有限公司 | 2024-10-18 | — | — | CN | disclosed |
| CN-107206085-B | Using alpha9Migration and release of HSCs for integrin antagonists and CXCR4 antagonists | 联邦科学和工业研究组织 | 2022-01-28 | — | — | CN | disclosed |
| US-10934309-B2 | Tricyclic quinone derivative | SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC. (US) | 2021-03-02 | — | — | US | disclosed |
| US-20200392098-A1 | SUBSTITUTED NAPHTHO[2,3-b]FURANS AS WATER-SOLUBLE PRODRUGS FOR PREVENTING AND/OR TREATING CANCER | BOSTON BIOMEDICAL, INC. (US) | 2020-12-17 | — | — | US | disclosed |
| US-10800752-B2 | Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer | BOSTON BIOMEDICAL, INC. (US) | 2020-10-13 | — | — | US | disclosed |
| EP-3686182-A1 | CHEMICALLY ACTIVATED WATER-SOLUBLE PRODRUG | Sumitomo Dainippon Pharma Co., Ltd. (JP) | 2020-07-29 | — | — | EP | disclosed |
| EP-0790235-A1 | Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses | SANKYO COMPANY LIMITED (JP) | 1997-08-20 | — | — | EP | disclosed |
| US-5556864-A | TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0410168-B1 | Process for the preparation of asymmetrically substituted ureas | CHEMIE LINZ GMBH (AT) | 1994-12-14 | — | — | EP | disclosed |
| EP-0600717-A1 | Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis | SANKYO COMPANY LIMITED (JP) | 1994-06-08 | — | — | EP | disclosed |
| EP-0202048-B1 | CARBAPENEM DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SANKYO COMPANY LIMITED (JP) | 1991-10-30 | — | — | EP | disclosed |
| US-4771046-A | ANTIBIOTICS | SANKYO COMPANY, LIMITED (JP) | 1988-09-13 | — | — | US | disclosed |
| EP-0202048-A1 | Carbapenem derivatives, their preparation, and pharmaceutical compositions containing them | SANKYO COMPANY LIMITED (JP) | 1986-11-20 | — | — | EP | disclosed |